Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Progr…

Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ...
New Atlas

FDA approval of ADHD brain device questioned after larger trial

The first-of-a-kind brain-stimulation device approved to treat attention-deficit/hyperactivity disorder (ADHD) in the US has ...
Seeking Alpha

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company offering non-invasive, rapid testing solutions, today ...
Seeking Alpha

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Rutland Herald

Surf Therapeutics Announces Early Feasibility Study (EFS) To Advance Non-Invasive Approach to Neuromodulation for Rheumatoid Arthritis

The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed ...
WHNT

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive ...

Application accepted for U.S. FDA Real-Time Oncology Review (RTOR) based on Phase 2b SunRISe-1 study showing highest single-agent complete response rate of 83.5 percent 1 RARITAN, N.J., Jan. 15, 2025 ...
Nasdaq

Intelligent Bio, Spjotgard Drive Shift To Non-Invasive Fingerprint Drug Testing In Scandinavia

(RTTNews) - Intelligent Bio Solutions Inc. (INBS) announced Wednesday the rapid expansion of its Intelligent Fingerprinting Drug Screening System across Sweden, Norway, and Denmark through its ...
Nasdaq

J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer Drug

Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational drug-device combination to treat certain patients with non-muscle invasive ...